NCT04963101
Unknown
Not Applicable
Characteristics of Transcriptome Expression Profile of PBMCs in Patients With Ossification of the Posterior Longitudinal Ligament
Fifth Affiliated Hospital, Sun Yat-Sen University1 site in 1 country30 target enrollmentStarted: June 25, 2021Last updated:
Overview
- Phase
- Not Applicable
- Sponsor
- Fifth Affiliated Hospital, Sun Yat-Sen University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- circRNA, lncRNA, mRNA
Overview
Brief Summary
In this study, we planned to identify transcriptome expression profiles (circRNAs, lncRNAs, and mRNAs) from peripheral blood mononuclear cells (PBMCs) of 30 patients with OPLL and 30 other non-OPLL patients by high-throughput sequencing.Sequence analysis was used to predict miRNAs that might bind circRNAs and lncRNAs.Through bioinformatics analysis, competitive endogenous RNAs (cerRNAs), as well as coexpression networks among circRNAs, lncRNAs, miRNAs, and mRNAs, were constructed to provide key molecules and signaling pathways associated with OPLL.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Voluntarily participate in the clinical study and sign the informed consent;
- •All OPLL patients meet the diagnostic criteria set out in the JOA Clinical Practice Guidelines for Spinal Ligament Osification 2019;
- •Age ≥18, gender unlimited;
- •All non-OPLL patients and healthy volunteers have no serious diseases of the heart, lung, brain, liver, kidney and blood system, such as autoimmune diseases, tumors, psychosis, infectious diseases, etc., and have no bad habits or recent history of taking special drugs.
Exclusion Criteria
- •Unable to sign the informed consent;
- •Patients who do not meet the inclusion criteria or diagnostic criteria;
- •\<18 years old;
- •Women planning to become pregnant/lactating/pregnant;
- •Complicated with serious heart, lung, brain, liver, kidney, blood system diseases, such as autoimmune diseases, tumors, mental illness, infectious diseases, drug addiction and other bad addicts;Those who have recently taken special drugs;
- •Individuals who do not agree to donate peripheral blood or who are obviously uncomfortable with drawing blood.
Outcomes
Primary Outcomes
circRNA, lncRNA, mRNA
Time Frame: 1 year
Secondary Outcomes
No secondary outcomes reported
Investigators
Huading Lu
Director of orthopaedics
Fifth Affiliated Hospital, Sun Yat-Sen University
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic PatientsAsthmaNCT00331292GlaxoSmithKline30
Unknown
Not Applicable
Neoadjuvant Chemotherapy in Locally Advanced Breast CancerBreast CancerNCT00820690Barretos Cancer Hospital80
Completed
Not Applicable
Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus InfectionNeonatal Herpes Simplex InfectionNeonatal HSV InfectionNeonatal InfectionNewborn; InfectionHerpes Simplex Virus InfectionNeonatal SepsisNeonatal DeathViral InfectionNCT05226949Rigshospitalet, Denmark159
Completed
Not Applicable
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's SyndromeHealthySicca SyndromeSjögren's SyndromeNCT02422407Biogen100
Terminated
Phase 4
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte MaturationEndometrial ReceptivityOvarian Hyperstimulation SyndromeNCT01606709UConn Health7